Stoke Therapeutics (STOK) Enterprise Value (2019 - 2026)
Stoke Therapeutics' Enterprise Value came in at $1.75 billion for Q2 2026, up 368.4% from $373.4 million a year earlier and up 3.9% from the prior quarter.
Powered by 
Analysis
Stoke Therapeutics (STOK) Enterprise Value (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Stoke Therapeutics reported Enterprise Value of $872.47 million; for FY2025, it was $1.59 billion, up 318.2% from FY2024.
- Enterprise Value carries a five-year compound annual growth rate of -4.3% (FY2020 to FY2025).
- Going back by year, Enterprise Value was $379.08 million in FY2024 (+844.5%), $40.14 million in FY2023 (-70.1%), $134.43 million in FY2022 (-79.8%) and $665.48 million in FY2021 (-66.4%).
- The Q2 2026 figure represents the highest quarterly Enterprise Value since Q4 2020.
- Year-over-year, Enterprise Value increased in four of the last six quarters, with growth averaging 262.5%.
- The fastest year-over-year change in Enterprise Value over five years came in Q4 2024 (growth of 844.5%), and the weakest in Q1 2025 (a decline of 98.7%).
- Business Quant data shows STOK's Enterprise Value at $1.68 billion (Q1 2026), $1.59 billion (Q4 2025) and $1.05 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Stoke Therapeutics | 1.59 Bn | 421.92 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.75 Bn |
| Mar 31, 2026 | 1.68 Bn |
| Dec 31, 2025 | 1.59 Bn |
| Sep 30, 2025 | 1.05 Bn |
| Jun 30, 2025 | 373.40 Mn |
| Mar 31, 2025 | 5.74 Mn |
| Dec 31, 2024 | 379.08 Mn |
| Sep 30, 2024 | 411.45 Mn |
| Jun 30, 2024 | 424.67 Mn |
| Mar 31, 2024 | 449.14 Mn |
| Dec 31, 2023 | 40.14 Mn |
| Sep 30, 2023 | -40.20 Mn |
| Jun 30, 2023 | 238.43 Mn |
| Mar 31, 2023 | 114.31 Mn |
| Dec 31, 2022 | 134.43 Mn |
| Sep 30, 2022 | 254.58 Mn |
| Jun 30, 2022 | 244.61 Mn |
| Mar 31, 2022 | 528.67 Mn |
| Dec 31, 2021 | 665.48 Mn |
| Sep 30, 2021 | 699.54 Mn |
API Access
Stoke Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=STOK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "STOK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=STOK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();